These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 14194557)
1. [OCULAR MANIFESTATIONS IN GRAVES-BASEDOW'S DISEASE. CLINICAL CHARACTERISTICS AND THERAPY]. KOMARNICKA R; FABISZEWSKA GORNA D Pol Arch Med Wewn; 1964; 34():1083-8. PubMed ID: 14194557 [No Abstract] [Full Text] [Related]
2. [Ocular manifestations of Basedow's disease. Therapeutic considerations apropos of 51 cases]. LINQUETTE M; FRANCOIS P; FOSSATI P; MAY JP; LEBRUN H Lille Med; 1963 Mar; 8():210-21. PubMed ID: 13930868 [No Abstract] [Full Text] [Related]
3. [ON THE THYROID STIMULATING ACTION OF BLOOD PLASMA FROM PATIENTS WITH BASEDOW'S DISEASE. (THE "LONG ACTING THYROID STIMULATOR" TEST IN BASEDOW'S DISEASE)]. FOELDES J; KRASZNAI I; GYERTYANFFY G Orv Hetil; 1965 May; 106():883-6. PubMed ID: 14305014 [No Abstract] [Full Text] [Related]
4. [Pathogenesis of diarrhea in Graves-Basedow's disease]. VENULET F Pol Tyg Lek (Wars); 1950 Jan; 5(3):81-3. PubMed ID: 15424052 [No Abstract] [Full Text] [Related]
5. [Roentgenterapy in Flaiani-Basedow's disease]. DALL'ACQUA V Radiol Med; 1947 Nov; 33(11):601. PubMed ID: 18907380 [No Abstract] [Full Text] [Related]
6. [Atypical Basedow's disease]. LINDEBOOM GA Ned Tijdschr Geneeskd; 1962 Dec; 106():2605-8. PubMed ID: 13930763 [No Abstract] [Full Text] [Related]
7. [Action of an antiserotonin substance on the ocular manifestations of Basedow's disease]. LINQUETTE M; FOSSATI P; MAY JP; LEBRUN H Ann Endocrinol (Paris); 1962; 23():457-64. PubMed ID: 13930867 [No Abstract] [Full Text] [Related]
8. [Basedow's disease]. DA SILVA MELLO A Rev Bras Med; 1946 Mar; 3():233-9. PubMed ID: 20984049 [No Abstract] [Full Text] [Related]
9. [Muscular miopragia in the course of Basedow's disease]. VOLTERRANI O Minerva Med; 1950 May; 41(25):831-4. PubMed ID: 15438808 [No Abstract] [Full Text] [Related]
10. [STUDY OF THE ULTRASTRUCTURE OF THE THYROID IN BASEDOW'S DISEASE AND IN NODULAR GOITER]. LUPULESCOU A C R Seances Soc Biol Fil; 1964; 158():1450-3. PubMed ID: 14250546 [No Abstract] [Full Text] [Related]
11. [Therapy of hypertoxic forms of Flaiani-Basedow's disease]. BASTAI P; BERETTA A Rass Clin Sci; 1948 Dec; 24(12):361-5. PubMed ID: 18111065 [No Abstract] [Full Text] [Related]
17. [Synthetic antithyroid substances in treatment of Basedow's disease]. BRULL L; LEFEBVRE L Rev Med Liege; 1950 Jun; 5(12):301-19. PubMed ID: 15430770 [No Abstract] [Full Text] [Related]
18. [A CASE OF BASEDOW'S DISEASE IN THE COURSE OF A THYROXIN TREATMENT OF SIMPLE GOITER (EXPLORATION WITH IODINE 131)]. GUINET P; TOURNIAIRE J; FRANCHET G; VEDRINNE J Ann Endocrinol (Paris); 1963; 24():835-41. PubMed ID: 14098746 [No Abstract] [Full Text] [Related]
19. THE EYE IN GRAVES' DISEASE. GILLILAND IC Postgrad Med J; 1964 Dec; 40(470):720-1. PubMed ID: 14227666 [No Abstract] [Full Text] [Related]
20. [Ocular manifestations of Basedow's disease and local administration of guanethidine]. Berkman N; Joseph E Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433 [No Abstract] [Full Text] [Related] [Next] [New Search]